Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention. Results of the GOLD (AU-Assessing Ultegra) Multicenter Study - Steinhubl,S.R.; Talley,D.; Braden,G.A. (Circulation, 2001)